Growth Metrics

Anaptysbio (ANAB) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to -$19.6 million.

  • Anaptysbio's Non Operating Income fell 9408.56% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.9 million, marking a year-over-year decrease of 20636.55%. This contributed to the annual value of -$30.3 million for FY2024, which is 394251.27% down from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Non Operating Income is -$19.6 million, which was down 9408.56% from -$12.4 million recorded in Q2 2025.
  • Anaptysbio's Non Operating Income's 5-year high stood at $424000.0 during Q3 2023, with a 5-year trough of -$19.6 million in Q3 2025.
  • Moreover, its 5-year median value for Non Operating Income was -$1.7 million (2024), whereas its average is -$4.6 million.
  • As far as peak fluctuations go, Anaptysbio's Non Operating Income skyrocketed by 11095.89% in 2023, and later tumbled by 1505000.0% in 2024.
  • Over the past 5 years, Anaptysbio's Non Operating Income (Quarter) stood at -$1.4 million in 2021, then skyrocketed by 69.88% to -$416000.0 in 2022, then surged by 80.77% to -$80000.0 in 2023, then crashed by 15050.0% to -$12.1 million in 2024, then tumbled by 61.64% to -$19.6 million in 2025.
  • Its Non Operating Income was -$19.6 million in Q3 2025, compared to -$12.4 million in Q2 2025 and -$11.7 million in Q1 2025.